Applied DNA Sciences Inc (NASDAQ:APDN) — Market Cap & Net Worth
Market Cap & Net Worth: Applied DNA Sciences Inc (APDN)
Applied DNA Sciences Inc (NASDAQ:APDN) has a market capitalization of $3.99 Million ($3.99 Million) as of May 22, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28924 globally and #5766 in its home market, demonstrating a 24.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Applied DNA Sciences Inc's stock price $3.09 by its total outstanding shares 1291465 (1.29 Million). Analyse Applied DNA Sciences Inc (APDN) cash conversion ratio to see how efficiently the company converts income to cash.
Applied DNA Sciences Inc Market Cap History: 2015 to 2025
Applied DNA Sciences Inc's market capitalization history from 2015 to 2025. Data shows change from $3.35 Billion to $3.99 Million (-53.34% CAGR).
Index Memberships
Applied DNA Sciences Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.94 Trillion | 0.00% | #2721 of 3165 |
Weight: Applied DNA Sciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Applied DNA Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Applied DNA Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.87x
Applied DNA Sciences Inc's market cap is 1.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.91 Billion | $4.19 Million | -$12.18 Million | 456.56x | N/A |
| 2017 | $1.64 Billion | $4.75 Million | -$12.86 Million | 345.75x | N/A |
| 2018 | $413.27 Million | $3.90 Million | -$11.69 Million | 105.88x | N/A |
| 2019 | $108.22 Million | $5.39 Million | -$8.63 Million | 20.08x | N/A |
| 2020 | $131.73 Million | $1.93 Million | -$12.76 Million | 68.20x | N/A |
| 2021 | $103.83 Million | $9.03 Million | -$16.03 Million | 11.50x | N/A |
| 2022 | $42.88 Million | $18.17 Million | -$8.38 Million | 2.36x | N/A |
| 2023 | $15.93 Million | $13.37 Million | -$9.95 Million | 1.19x | N/A |
| 2024 | $263.46K | $3.43 Million | -$6.99 Million | 0.08x | N/A |
| 2025 | $3.99 Million | $2.14 Million | -$69.49 Million | 1.87x | N/A |
Competitor Companies of APDN by Market Capitalization
Companies near Applied DNA Sciences Inc in the global market cap rankings as of May 22, 2026.
Key companies related to Applied DNA Sciences Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #129 globally with a market cap of $169.74 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #198 globally with a market cap of $120.87 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #607 globally with a market cap of $43.67 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #656 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Thermo Fisher Scientific Inc | NYSE:TMO | $169.74 Billion | $451.79 |
| #198 | Danaher Corporation | NYSE:DHR | $120.87 Billion | $171.12 |
| #607 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.67 Billion | $553.58 |
| #656 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Applied DNA Sciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Applied DNA Sciences Inc's market cap moved from $3.35 Billion to $ 3.99 Million, with a yearly change of -53.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.99 Million | +1414.71% |
| 2024 | $263.46K | -98.35% |
| 2023 | $15.93 Million | -62.84% |
| 2022 | $42.88 Million | -58.71% |
| 2021 | $103.83 Million | -21.18% |
| 2020 | $131.73 Million | +21.72% |
| 2019 | $108.22 Million | -73.81% |
| 2018 | $413.27 Million | -74.84% |
| 2017 | $1.64 Billion | -14.05% |
| 2016 | $1.91 Billion | -42.90% |
| 2015 | $3.35 Billion | -- |
End of Day Market Cap According to Different Sources
On May 21st, 2026 the market cap of Applied DNA Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.99 Million USD |
| MoneyControl | $3.99 Million USD |
| MarketWatch | $3.99 Million USD |
| marketcap.company | $3.99 Million USD |
| Reuters | $3.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Applied DNA Sciences Inc
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops… Read more